EP1261354A1 - Applikations-system und verfahren zur gentherapie - Google Patents
Applikations-system und verfahren zur gentherapieInfo
- Publication number
- EP1261354A1 EP1261354A1 EP00904645A EP00904645A EP1261354A1 EP 1261354 A1 EP1261354 A1 EP 1261354A1 EP 00904645 A EP00904645 A EP 00904645A EP 00904645 A EP00904645 A EP 00904645A EP 1261354 A1 EP1261354 A1 EP 1261354A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- gene therapy
- set forth
- nucleic acid
- carbohydrate
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US495675 | 2000-02-01 | ||
US09/495,675 US6500807B1 (en) | 1999-02-02 | 2000-02-01 | Modified pectin and nucleic acid composition |
PCT/US2000/002628 WO2000045825A1 (en) | 1999-02-02 | 2000-02-02 | Delivery system and methods for gene therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1261354A1 true EP1261354A1 (de) | 2002-12-04 |
EP1261354A4 EP1261354A4 (de) | 2004-09-15 |
Family
ID=23969560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00904645A Withdrawn EP1261354A4 (de) | 2000-02-01 | 2000-02-02 | Applikations-system und verfahren zur gentherapie |
Country Status (1)
Country | Link |
---|---|
EP (1) | EP1261354A4 (de) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5895784A (en) * | 1994-07-07 | 1999-04-20 | Michigan Cancer Foundation | Method for treatment of cancer by oral administration of modified pectin |
-
2000
- 2000-02-02 EP EP00904645A patent/EP1261354A4/de not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5895784A (en) * | 1994-07-07 | 1999-04-20 | Michigan Cancer Foundation | Method for treatment of cancer by oral administration of modified pectin |
Non-Patent Citations (2)
Title |
---|
PLATT DAVID ET AL: "Effect of a modified natural complex carbohydrates in cancer" ABSTRACTS OF PAPERS AMERICAN CHEMICAL SOCIETY, vol. 219, no. 1-2, 2000, page CARB 62, XP009033721 & 219TH MEETING OF THE AMERICAN CHEMICAL SOCIETY.; SAN FRANCISCO, CALIFORNIA, USA; MARCH 26-30, 2000 ISSN: 0065-7727 * |
See also references of WO0045825A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1261354A4 (de) | 2004-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6500807B1 (en) | Modified pectin and nucleic acid composition | |
US20200230259A1 (en) | Isolation of extracellular vesicles (evs) from red blood cells for gene therapy | |
JP2002500662A (ja) | 核酸と細胞外マトリックスを崩壊させる物質とを組み合わせた遺伝子治療用組合せ製剤 | |
US9801953B2 (en) | Nanoparticles carrying nucleic acid cassettes for expressing RNA | |
Bansal et al. | Gene therapy for brain tumors | |
Kammertoens et al. | Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine | |
CA2530125A1 (en) | Use of double-stranded ribonucleic acid for inducing cell lysis | |
WO2001097857A1 (fr) | Preparations destinees au transfert d'oligonucleotides | |
Saraswat et al. | DNA as therapeutics; an update | |
EP1261354A1 (de) | Applikations-system und verfahren zur gentherapie | |
US20170348345A1 (en) | Combination Therapy For Cancer | |
JP7138234B2 (ja) | 組み換え単純ヘルペスウイルス及びその製造方法 | |
JP2003503308A (ja) | 遺伝子治療の送達系及び方法 | |
Braun | History of Gene Therapy | |
AU2004217830B2 (en) | A recombinant constructed by a virus vector and a human tumor suppressor gene and its use | |
Collis et al. | Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy | |
KR100342382B1 (ko) | 간암 특이적 세포 살상 재조합 아데노바이러스 | |
CN101642462B (zh) | 一种肿瘤抑制剂nrn1sr42 | |
CN117778474A (zh) | 一种基于CRISPR-Cas13a靶向敲低癌基因的表达载体及其应用 | |
CN101643729B (zh) | 核酸分子nrn1sr22及其在制备抗癌药物中的应用 | |
CN101503437B (zh) | 核酸分子si-cypj-4及其在制备抗癌药物中的应用 | |
CA3135295A1 (en) | Modified adenovirus and medicine comprising same | |
Maguire et al. | Gene therapy for retinal disease | |
CN101328475B (zh) | 核酸分子nrn1sr1及其在制备抗癌药物中的应用 | |
CN100510071C (zh) | 核酸分子rtn4bsr3及其在制备抗癌药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020830 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040802 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61K 48/00 J Ipc: 7A 61K 31:715 J Ipc: 7A 61K 48/00 B Ipc: 7C 12N 15/63 B Ipc: 7A 61K 31/715 A |
|
17Q | First examination report despatched |
Effective date: 20060821 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: GLYCOGENESYS, INC. |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: PROSPECT THERAPEUTICS, INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080822 |